Literature DB >> 25887774

Classification, diagnosis, and differential diagnosis of multiple sclerosis.

Ilana Katz Sand1.   

Abstract

PURPOSE OF REVIEW: The increasing availability of effective therapies for multiple sclerosis as well as research demonstrating the benefits of early treatment highlights the importance of expedient and accurate multiple sclerosis diagnosis. This review will discuss the classification, diagnosis, and differential diagnosis of multiple sclerosis. RECENT
FINDINGS: An international panel of multiple sclerosis experts, the MS Phenotype Group, recently revised the multiple sclerosis phenotypic classifications and published their recommendations in 2014. Recent research developments have helped improve the accuracy of multiple sclerosis diagnosis, especially with regard to differentiating multiple sclerosis from neuromyelitis optica spectrum disorders.
SUMMARY: Current multiple sclerosis phenotypic classifications include relapsing-remitting multiple sclerosis, clinically isolated syndrome, radiologically isolated syndrome, primary-progressive multiple sclerosis, and secondary-progressive multiple sclerosis. The McDonald 2010 diagnostic criteria provide formal guidelines for the diagnosis of relapsing-remitting multiple sclerosis and primary-progressive multiple sclerosis. These require demonstration of dissemination in space and time, with consideration given to both clinical findings and imaging data. The criteria also require that there exist no better explanation for the patient's presentation. The clinical history, examination, and MRI should be most consistent with multiple sclerosis, including the presence of features typical for the disease as well as the absence of features that suggest an alternative cause, for a diagnosis of multiple sclerosis to be proposed.

Entities:  

Mesh:

Year:  2015        PMID: 25887774     DOI: 10.1097/WCO.0000000000000206

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  43 in total

1.  Serum uric acid concentrations are directly associated with the presence of benign multiple sclerosis.

Authors:  Esteban Simental-Mendía; Luis E Simental-Mendía; Fernando Guerrero-Romero
Journal:  Neurol Sci       Date:  2017-06-28       Impact factor: 3.307

2.  A Young Woman With Sudden Urinary Retention and Sensory Deficits.

Authors:  Sarah L Patterson; Kashif Jafri; Jared A Narvid; Mary Margaretten
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-18       Impact factor: 4.794

Review 3.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

4.  Pelvic floor muscle training adapted for urinary incontinence in multiple sclerosis: a randomized clinical trial.

Authors:  Denise Cuevas Pérez; Carolina Walker Chao; Lucía Llanos Jiménez; Ignacio Mahíllo Fernández; Ana Isabel de la Llave Rincón
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

Review 5.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

6.  Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination.

Authors:  Andrea Pennati; Emily A Nylen; Ian D Duncan; Jacques Galipeau
Journal:  J Neurosci       Date:  2020-05-19       Impact factor: 6.167

Review 7.  DNA Methylation: a New Player in Multiple Sclerosis.

Authors:  Xiang Li; Bing Xiao; Xing-Shu Chen
Journal:  Mol Neurobiol       Date:  2016-06-17       Impact factor: 5.590

8.  Cannabinoid Receptors and Ligands: Lessons from CNS Disorders and the Quest for Novel Treatment Venues.

Authors:  Clara M Vecchini Rodríguez; Yma Escalona Meléndez; Jacqueline Flores-Otero
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Encephalitogenic and Regulatory CD8 T Cells in Multiple Sclerosis and Its Animal Models.

Authors:  Taryn E Mockus; Ashley Munie; Jeffrey R Atkinson; Benjamin M Segal
Journal:  J Immunol       Date:  2021-01-01       Impact factor: 5.422

Review 10.  Glial restricted precursor cells in central nervous system disorders: Current applications and future perspectives.

Authors:  Joana Martins-Macedo; Angelo C Lepore; Helena S Domingues; António J Salgado; Eduardo D Gomes; Luísa Pinto
Journal:  Glia       Date:  2020-10-14       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.